CONCUSSION DRUG STUDY SHOWS POSITIVE EARLY RESULTS
BioPharma
Stay updated with breaking news from Michael Wyand. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Responses to an article about soldiers who have brain damage from firing heavy weapons. Also: Mike Johnson; Capitol fighting; climate change; preventing falls.
Phase 2 clinical trial for OXE103 for the treatment of concussion is being conducted at University of Kansas Medical Center, Kansas City, KansasEnrolling...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
OXEIA BIOPHARMACEUTICALS ANNOUNCES NEW BOARD AND MANAGEMENT TEAM MEMBERS AND RELOCATES CORPORATE HEADQUARTERS TO BOSTON - read this article along with other careers information, tips and advice on BioSpace